PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, USA. ksantosh@uthsc.edu.\', \'Department of Anesthesiology, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.\', \'Cellular and Molecular Neuroscience, National Brain Research Center, Panesar, Haryana, India.\', \'Department of Pharmacology and Physiology, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY, USA.\', \'Department of Microbiology, Immunology & Tropical Medicine, George Washington University School of Medicine and Health Sciences, Washington D.C., USA.\', \'Institute of Neuroimmune Pharmacology and Department of Biological Sciences, Seton Hall University, South Orange, NJ, USA. sulie.chang@shu.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s11481-021-10038-z
?:doi
?:hasPublicationType
?:journal
  • Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 34935110
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • The Neuroimmune Pharmacology of SARS-CoV-2.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34935110>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34935110>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all